CAS 849217-68-1 appears in our catalog under these names: Cabozantinib, XL184, >95% (HPLC), Cabozantinib/ 99.88% (existing batch purity), Cabozantinib (XL184, BMS–907351), XL184. Offered by: Chemat Brand, TRC, TargetMol, GLPBio, Biosynth. Available pack sizes: on request, 1g, 250mg, 500mg, 5mg, 10mg, 50mg, 100mg.
Cabozantinib is a dicarboxylic acid diamide that is N-phenyl-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide in which the hydrogen at position 4 on the phenyl ring is substituted by a (6,7-dimethoxyquinolin-4-yl)oxy group. A multi-tyrosine kinase inhibitor, used (as its malate salt) for the treatment of progressive, metastatic, medullary thyroid cancer. It has a role as an antineoplastic agent and a tyrosine kinase inhibitor. It is a member of quinolines, an aromatic ether, a dicarboxylic acid diamide and an organofluorine compound.
Source: ChEBI
| Molecular formula | C28H24FN3O5 |
|---|---|
| Molecular weight | 501.5 g/mol |
| IUPAC name | 1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
| InChIKey | ONIQOQHATWINJY-UHFFFAOYSA-N |
| SMILES | COC1=CC2=C(C=CN=C2C=C1OC)OC3=CC=C(C=C3)NC(=O)C4(CC4)C(=O)NC5=CC=C(C=C5)F |
Computed by PubChem (NCBI)